Delivery Order SPE2DB20D3103-SPE2DB25FN6N3

Award Date 5/1/25
Potential Completion Date 5/2/25
Potential Value $2.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Premarin 0.3 mg tablets. The contract has a ceiling value of $2,019.10 and is a firm fixed-price delivery order with an ultimate completion date of April 18, 2025. The contract is not set aside and is open to full and open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,402.87, is for the delivery of Premarin 0.625 mg tablets. It is a firm fixed-price contract with a performance period ending on May 8, 2025. The contract is not set aside for any specific type of business. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Premarin 0.9 mg tablets. The firm-fixed-price contract, valued at $2,372.60, has a completion date of November 5, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC covers a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation in the amount of $1,151.91. The contract is for the supply of Premarin 0.625 mg tablets, a prescription medication. The contract has an ultimate completion date of September 19, 2024, and is a firm-fixed price delivery order with no set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, is the prime contractor for this award, which falls under the company's...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Premarin 0.625 mg tablets. The contract, valued at $12,604.06, was awarded on April 26, 2022, with an ultimate completion date of April 27, 2022. This order is part of a larger Indefinite Delivery Contract (IDC) held by the parent company, Cencora, Inc., doing business as AmerisourceBergen, with the DLA Troop Support Medical valued at up...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of PREMARIN 0.625 mg tablets. The contract has a ceiling value of $15,780.06 and an ultimate completion date of February 26, 2024. The contract is not designated with a set-aside requirement, indicating it was competitively awarded. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that supplies a wide...
This is a delivery order issued by the Defense Logistics Agency (DLA) to the pharmaceutical distributor AmerisourceBergen Drug Corporation for the supply of Premarin 1.25 mg tablets in 100-count packages. The contract has a ceiling value of $7,158.85 and a completion date of September 6, 2024. It is a firm-fixed-price contract. This order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at up to $999,999,999, for...
This is a $3,705.82 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Premarin 0.625 mg tablets, a medication used in hormone replacement therapy. The contract has an ultimate completion date of May 8, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Premarin 0.625 mg tablets. The contract has a ceiling value of $13,027.95 and a period of performance running through May 20, 2022. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which also...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,421.37, is for the delivery of Premarin 0.625 mg tablets in 100-count bottles. The contract is a delivery order type with a firm fixed price, and the ultimate completion date is March 27, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB25FN6N3
    Delivery Order

This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Premarin 0.625 mg tablets. The contract has a ceiling value of $2,417.34 and an ultimate completion date of May 2, 2025. The contract is not set aside and was awarded on May 1, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This delivery order is likely part of the company's broader support of federal medical procurement needs, particularly for military and veteran healthcare systems.

Generated 8/3/25, 1:34 AM